评估心脏肾上腺素能成像指导植入式心律转复除颤器（ICD）使用能力时个体患者特征的重要性。 - Suppr

Importance of individual patient characteristics when assessing the ability of cardiac adrenergic imaging to guide ICD use.

作者信息

Travin Mark I

机构信息

Division of Nuclear Medicine, Department of Radiology, Montefiore Medical Center and the Albert Einstein College of Medicine, 111 E. 210th Street, Bronx, NY, 10467-2490, USA.

出版信息

J Nucl Cardiol. 2022 Apr;29(2):692-697. doi: 10.1007/s12350-020-02387-8. Epub 2020 Oct 20.

DOI:10.1007/s12350-020-02387-8

PMID:33083985

Abstract

摘要

相似文献

Importance of individual patient characteristics when assessing the ability of cardiac adrenergic imaging to guide ICD use.评估心脏肾上腺素能成像指导植入式心律转复除颤器（ICD）使用能力时个体患者特征的重要性。

J Nucl Cardiol. 2022 Apr;29(2):692-697. doi: 10.1007/s12350-020-02387-8. Epub 2020 Oct 20.

Protein biomarkers identify patients unlikely to benefit from primary prevention implantable cardioverter defibrillators: findings from the Prospective Observational Study of Implantable Cardioverter Defibrillators (PROSE-ICD).蛋白质生物标志物可识别出不太可能从一级预防植入式心脏复律除颤器中获益的患者：植入式心脏复律除颤器前瞻性观察研究（PROSE-ICD）的结果。

Circ Arrhythm Electrophysiol. 2014 Dec;7(6):1084-91. doi: 10.1161/CIRCEP.113.001705. Epub 2014 Oct 1.

Implantable cardiac arrhythmia devices--Part II: implantable cardioverter defibrillators and implantable loop recorders.植入式心律失常器械——第二部分：植入式心脏复律除颤器和植入式循环记录仪

Clin Cardiol. 2006 Jun;29(6):237-42. doi: 10.1002/clc.4960290603.

Implantable defibrillators versus medical therapy for cardiac channelopathies.植入式除颤器与心脏离子通道病的药物治疗对比

Cochrane Database Syst Rev. 2015 Oct 7;2015(10):CD011168. doi: 10.1002/14651858.CD011168.pub2.

Imaging for assessment of sudden death risk: current role and future prospects.用于评估猝死风险的影像学检查：当前作用与未来前景

Europace. 2016 Oct;18(10):1491-1500. doi: 10.1093/europace/euv456. Epub 2016 Apr 20.

Sudden cardiac death: New approaches for implantable cardioverter-defibrillators (ICDs).心脏性猝死：植入式心脏复律除颤器（ICD）的新方法。

Int J Cardiol. 2017 Jun 15;237:38-41. doi: 10.1016/j.ijcard.2017.03.064. Epub 2017 Mar 18.

[Sudden cardiac death in the youth. Is the new subcutaneous implantable cardioverter defibrillator S-ICD an alternative solution?].[青年心脏性猝死。新型皮下植入式心律转复除颤器S-ICD是一种替代解决方案吗？]

Ann Cardiol Angeiol (Paris). 2015 Feb;64(1):27-31. doi: 10.1016/j.ancard.2014.08.018. Epub 2014 Sep 18.

[ICD therapy in the primary prevention of sudden cardiac death: Risk stratification and patient selection].[心脏性猝死一级预防中的植入式心律转复除颤器治疗：风险分层与患者选择]

Herzschrittmacherther Elektrophysiol. 2015 Jun;26(2):75-81. doi: 10.1007/s00399-015-0371-9. Epub 2015 Jun 4.

Sudden Death in Patients With Cardiac Implantable Electronic Devices.心脏植入式电子设备患者的猝死。

JAMA Intern Med. 2015 Aug;175(8):1342-50. doi: 10.1001/jamainternmed.2015.2641.

Cost-benefit analysis of primary prevention of sudden cardiac death with an implantable cardioverter defibrillator versus amiodarone in Canada.加拿大植入式心脏复律除颤器与胺碘酮用于心源性猝死一级预防的成本效益分析。

Curr Med Res Opin. 2009 Mar;25(3):617-26. doi: 10.1185/03007990802695037.

引用本文的文献

Cardiac I-mIBG scintigraphy for prediction of catheter ablation outcome in patients with atrial fibrillation.心脏 I-mIBG 闪烁显像术预测心房颤动患者导管消融治疗的效果。

J Nucl Cardiol. 2022 Oct;29(5):2220-2231. doi: 10.1007/s12350-021-02658-y. Epub 2021 May 27.

本文引用的文献

Denervated Myocardium Is Preferentially Associated With Sudden Cardiac Arrest in Ischemic Cardiomyopathy: A Pilot Competing Risks Analysis of Cause-Specific Mortality.失神经支配心肌与缺血性心肌病患者的心源性猝死优先相关：一项关于特定病因死亡率的先导性竞争风险分析

Circ Cardiovasc Imaging. 2017 Aug;10(8). doi: 10.1161/CIRCIMAGING.117.006446.

Predicting Risk Versus Predicting Potential Survival Benefit Using 123I-mIBG Imaging in Patients With Systolic Dysfunction Eligible for Implantable Cardiac Defibrillator Implantation: Analysis of Data From the Prospective ADMIRE-HF Study.在适合植入植入式心脏除颤器的收缩功能障碍患者中，使用123I-间碘苄胍成像预测风险与预测潜在生存获益：来自前瞻性ADMIRE-HF研究的数据分析。

Circ Cardiovasc Imaging. 2015 Dec;8(12). doi: 10.1161/CIRCIMAGING.114.003110.

Novel Imaging Approaches for Predicting Arrhythmic Risk.预测心律失常风险的新型成像方法

Circ Cardiovasc Imaging. 2015 Nov;8(11):e003019. doi: 10.1161/CIRCIMAGING.115.003019.

Assessment of underlying etiology and cardiac sympathetic innervation to identify patients at high risk of cardiac death.评估潜在病因和心脏交感神经支配以识别心脏性死亡高危患者。

J Nucl Med. 2001 Dec;42(12):1757-67.

Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure.心力衰竭患者心肌碘苄胍显像的预后价值

J Nucl Med. 1992 Apr;33(4):471-7.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Importance of individual patient characteristics when assessing the ability of cardiac adrenergic imaging to guide ICD use.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献